(HELE) Helen of Troy - Overview
Stock: Kitchenware, Hydration, Backpacks, Hair Care, Wellness Devices
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 49.8% |
| Relative Tail Risk | -13.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.60 |
| Alpha | -94.35 |
| Character TTM | |
|---|---|
| Beta | 1.311 |
| Beta Downside | 1.452 |
| Drawdowns 3y | |
|---|---|
| Max DD | 88.32% |
| CAGR/Max DD | -0.55 |
Description: HELE Helen of Troy December 26, 2025
Helen of Troy Ltd. (NASDAQ: HELE) designs, manufactures, and markets a diversified portfolio of consumer products across two segments – Home & Outdoor and Beauty & Wellness – serving North America, Europe, the Middle East, Africa, APAC and Latin America.
The Home & Outdoor segment includes food-storage and kitchen tools, insulated beverageware, and a range of travel-and-sports packs (e.g., OXO, Hydro Flask, Osprey). The Beauty & Wellness segment covers hair-care appliances and grooming tools (Hot Tools, Curlsmith) as well as health-monitoring devices and water-air filtration systems (PUR).
In FY 2023 the company generated $2.0 billion of revenue, up 5 % year-over-year, with an adjusted EBITDA margin of ~13 % and a diluted EPS of $2.10 – both modestly above the household-appliance sub-industry averages, reflecting strong brand pricing power and efficient supply-chain management.
Key drivers for HELE include continued consumer spending on premium home-goods as remote-work persists, and the secular shift toward health-focused indoor air-quality products, which have grown at ~8 % CAGR globally. However, exposure to raw-material cost volatility (e.g., plastics, aluminum) and a modest slowdown in discretionary retail traffic remain material risks.
For a deeper, data-driven valuation, see the HELE profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -792.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.68 > 1.0 |
| NWC/Revenue: 24.97% < 20% (prev 25.04%; Δ -0.07% < -1%) |
| CFO/TA 0.04 > 3% & CFO 94.8m > Net Income -792.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.81 > 1.5 & < 3 |
| Outstanding Shares: last quarter (23.0m) vs 12m ago 0.67% < -2% |
| Gross Margin: 46.72% > 18% (prev 0.48%; Δ 4624 % > 0.5%) |
| Asset Turnover: 67.83% > 50% (prev 64.27%; Δ 3.55% > 0%) |
| Interest Coverage Ratio: -4.30 > 6 (EBITDA TTM -198.9m / Interest Expense TTM 58.8m) |
Altman Z'' 1.61
| A: 0.19 (Total Current Assets 1.00b - Total Current Liabilities 554.1m) / Total Assets 2.34b |
| B: 0.20 (Retained Earnings 468.4m / Total Assets 2.34b) |
| C: -0.10 (EBIT TTM -252.8m / Avg Total Assets 2.66b) |
| D: 0.32 (Book Value of Equity 469.3m / Total Liabilities 1.49b) |
| Altman-Z'' Score: 1.61 = BB |
Beneish M -3.57
| DSRI: 1.00 (Receivables 444.1m/468.5m, Revenue 1.80b/1.91b) |
| GMI: 1.03 (GM 46.72% / 48.04%) |
| AQI: 0.75 (AQ_t 0.41 / AQ_t-1 0.54) |
| SGI: 0.94 (Revenue 1.80b / 1.91b) |
| TATA: -0.38 (NI -792.5m - CFO 94.8m) / TA 2.34b) |
| Beneish M-Score: -3.57 (Cap -4..+1) = AAA |
What is the price of HELE shares?
Over the past week, the price has changed by -9.51%, over one month by -22.14%, over three months by -13.39% and over the past year by -73.96%.
Is HELE a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HELE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 28 | 69.1% |
| Analysts Target Price | 28 | 69.1% |
| ValueRay Target Price | 8.4 | -49.5% |
HELE Fundamental Data Overview January 29, 2026
P/S = 0.2258
P/B = 0.4813
P/EG = 0.9718
Revenue TTM = 1.80b USD
EBIT TTM = -252.8m USD
EBITDA TTM = -198.9m USD
Long Term Debt = 869.0m USD (from longTermDebt, last quarter)
Short Term Debt = 23.4m USD (from shortTermDebt, last quarter)
Debt = 946.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 919.7m USD (from netDebt column, last quarter)
Enterprise Value = 1.32b USD (407.0m + Debt 946.9m - CCE 29.7m)
Interest Coverage Ratio = -4.30 (Ebit TTM -252.8m / Interest Expense TTM 58.8m)
EV/FCF = 16.41x (Enterprise Value 1.32b / FCF TTM 80.7m)
FCF Yield = 6.09% (FCF TTM 80.7m / Enterprise Value 1.32b)
FCF Margin = 4.48% (FCF TTM 80.7m / Revenue TTM 1.80b)
Net Margin = -43.98% (Net Income TTM -792.5m / Revenue TTM 1.80b)
Gross Margin = 46.72% ((Revenue TTM 1.80b - Cost of Revenue TTM 960.2m) / Revenue TTM)
Gross Margin QoQ = 46.87% (prev 44.16%)
Tobins Q-Ratio = 0.57 (Enterprise Value 1.32b / Total Assets 2.34b)
Interest Expense / Debt = 1.67% (Interest Expense 15.9m / Debt 946.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = -199.7m (EBIT -252.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.81 (Total Current Assets 1.00b / Total Current Liabilities 554.1m)
Debt / Equity = 1.11 (Debt 946.9m / totalStockholderEquity, last quarter 852.3m)
Debt / EBITDA = -4.63 (negative EBITDA) (Net Debt 919.7m / EBITDA -198.9m)
Debt / FCF = 11.40 (Net Debt 919.7m / FCF TTM 80.7m)
Total Stockholder Equity = 1.17b (last 4 quarters mean from totalStockholderEquity)
RoA = -29.83% (Net Income -792.5m / Total Assets 2.34b)
RoE = -67.60% (Net Income TTM -792.5m / Total Stockholder Equity 1.17b)
RoCE = -12.39% (EBIT -252.8m / Capital Employed (Equity 1.17b + L.T.Debt 869.0m))
RoIC = -9.67% (negative operating profit) (NOPAT -199.7m / Invested Capital 2.07b)
WACC = 4.16% (E(407.0m)/V(1.35b) * Re(10.75%) + D(946.9m)/V(1.35b) * Rd(1.67%) * (1-Tc(0.21)))
Discount Rate = 10.75% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.65%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈97.5m ; Y1≈64.0m ; Y5≈29.2m
Fair Price DCF = 0.47 (EV 930.6m - Net Debt 919.7m = Equity 10.8m / Shares 23.1m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -57.23 | EPS CAGR: -9.73% | SUE: -0.21 | # QB: 0
Revenue Correlation: -55.03 | Revenue CAGR: -3.32% | SUE: 0.61 | # QB: 0
EPS next Quarter (2026-05-31): EPS=-0.01 | Chg30d=-0.242 | Revisions Net=-2 | Analysts=3
EPS next Year (2027-02-28): EPS=3.38 | Chg30d=-0.823 | Revisions Net=-5 | Growth EPS=-2.6% | Growth Revenue=+0.6%